Dr. Daniel C. Ramirez is an Assistant Attending Pathologist at HSS with special interest in the diagnosis of neoplastic and non-neoplastic conditions of bone, joints, and soft tissues.
Dr. Ramirez received his medical degree from University of Medicine and Dentistry of New Jersey - New Jersey Medical School in Newark, New Jersey. He trained in Anatomic and Clinical Pathology at Rutgers - New Jersey Medical School followed by fellowships in Surgical Oncologic Pathology at Memorial Sloan Kettering Cancer Center and Orthopedic Pathology at HSS.
Assistant Attending Pathologist, Hospital for Special Surgery
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of , Dr. Ramirez reported no relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
University of Medicine and Dentistry of New Jersey, New Jersey Medical School, 2011
Rutgers New Jersey Medical School, 2015
Surgical Oncologic Pathology, Memorial Sloan Kettering Cancer Center, 2016
Orthopedic Pathology, Hospital for Special Surgery, 2017
Zhu GG, Ramirez D, Chen W, Lu C, Wang L, Frosina D, Jungbluth A, Ntiamoah P, Nafa K, Boland PJ, Hameed MR. Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma. Hum Pathol. 2020 Oct;104:73-83. doi: 10.1016/j.humpath.2020.07.002. Epub 2020 Aug 12. PMID: 32795465.
Gundle KR, Deutsch GB, Goodman HJ, Pollack SM, Thompson MJ, Davis JL, Lee MY, Ramirez DC, Kerwin W, Bertout JA, Grenley MO, Sottero KHW, Beirne E, Frazier J, Dey J, Ellison M, Klinghoffer RA, Maki RG. Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma. Clin Cancer Res. 2020 Aug 1;26(15):3958-3968. doi: 10.1158/1078-0432.CCR-20-0614. Epub 2020 Apr 16. PMID: 32299817.
Lu C, Ramirez D, Hwang S, Jungbluth A, Frosina D, Ntiamoah P, Healey J, Zhu G, Chen W, Klein M, Hameed M.
Histone H3K36M mutation and trimethylation patterns in chondroblastoma. Histopathology. 2019 Jan;74(2):291-299. doi: 10.1111/his.13725. Epub 2018 Nov 4. PMID: 30098026; PMCID: PMC6298805.